Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.
CONCLUSION: RTX could be an effective and relatively safe therapeutic option in patients with refractory IIM.
PMID: 32989931 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
More News: Biomedical Science | Corticosteroid Therapy | Prednisolone | Rheumatology | Rituxan | Science